Medical Products Company
Oxford Immunotec Global has acquired 3 companies of its own, including 2 in the last 5 years.
Oxford Immunotec Global’s largest acquisition to date was in 2016, when it acquired Imugen for $22M. Oxford Immunotec Global has acquired in 2 different US states. The Company’s most targeted sectors include life science (34%) and medical products (34%).
Join Mergr and gain access to Oxford Immunotec Global’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.
M&A Total Activity3
- M&A Buy Activity3
- Total Sectors Invested 3
- Total Countries Invested 1